These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25890140)

  • 1. Bench to bedside: challenges of clinical translation.
    Steeves JD
    Prog Brain Res; 2015; 218():227-39. PubMed ID: 25890140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Inclusive Trial Protocols in Heterogeneous Neurological Disorders: Prediction-Based Stratification of Participants With Incomplete Cervical Spinal Cord Injury.
    Tanadini LG; Hothorn T; Jones LA; Lammertse DP; Abel R; Maier D; Rupp R; Weidner N; Curt A; Steeves JD
    Neurorehabil Neural Repair; 2015 Oct; 29(9):867-77. PubMed ID: 25644238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational research in spinal cord injury: a survey of opinion from the SCI community.
    Kwon BK; Hillyer J; Tetzlaff W
    J Neurotrauma; 2010 Jan; 27(1):21-33. PubMed ID: 19751098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures.
    Steeves JD; Lammertse D; Curt A; Fawcett JW; Tuszynski MH; Ditunno JF; Ellaway PH; Fehlings MG; Guest JD; Kleitman N; Bartlett PF; Blight AR; Dietz V; Dobkin BH; Grossman R; Short D; Nakamura M; Coleman WP; Gaviria M; Privat A;
    Spinal Cord; 2007 Mar; 45(3):206-21. PubMed ID: 17179972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opinions on the preclinical evaluation of novel therapies for spinal cord injury: a comparison between researchers and spinal cord-injured individuals.
    Kwon BK; Ghag A; Reichl L; Dvorak MF; Illes J; Tetzlaff W
    J Neurotrauma; 2012 Sep; 29(14):2367-74. PubMed ID: 22776047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials in spinal cord injury: lessons learned on the path to translation. The 2011 International Spinal Cord Society Sir Ludwig Guttmann Lecture.
    Lammertse DP
    Spinal Cord; 2013 Jan; 51(1):2-9. PubMed ID: 23165505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials in spinal cord injury.
    Blight AR; Tuszynski MH
    J Neurotrauma; 2006; 23(3-4):586-93. PubMed ID: 16629639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translating preclinical approaches into human application.
    Dietz V; Curt A
    Handb Clin Neurol; 2012; 109():399-409. PubMed ID: 23098727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rocky road to translation in spinal cord repair.
    Filli L; Schwab ME
    Ann Neurol; 2012 Oct; 72(4):491-501. PubMed ID: 23109144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury.
    Tator CH; Hashimoto R; Raich A; Norvell D; Fehlings MG; Harrop JS; Guest J; Aarabi B; Grossman RG
    J Neurosurg Spine; 2012 Sep; 17(1 Suppl):157-229. PubMed ID: 22985382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From bench to beside to cure spinal cord injury: lost in translation?
    Hug A; Weidner N
    Int Rev Neurobiol; 2012; 106():173-96. PubMed ID: 23211464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal cord injury clinical trials translational process, review of past and proposed acute trials with reference to recommended trial guidelines.
    Steeves J; Blight A
    Handb Clin Neurol; 2012; 109():386-98. PubMed ID: 23098726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating mechanisms of neuroprotection, regeneration, and repair to treatment of spinal cord injury.
    Siddiqui AM; Khazaei M; Fehlings MG
    Prog Brain Res; 2015; 218():15-54. PubMed ID: 25890131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the bench to the body: key issues associated with research aimed at a cure for SCI.
    Sipski ML
    J Rehabil Res Dev; 2003; 40(4 Suppl 1):1-7. PubMed ID: 15080085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design.
    Lammertse D; Tuszynski MH; Steeves JD; Curt A; Fawcett JW; Rask C; Ditunno JF; Fehlings MG; Guest JD; Ellaway PH; Kleitman N; Blight AR; Dobkin BH; Grossman R; Katoh H; Privat A; Kalichman M;
    Spinal Cord; 2007 Mar; 45(3):232-42. PubMed ID: 17179970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The translational dialogue in spinal cord injury research.
    Curt A
    Spinal Cord; 2012 May; 50(5):352-7. PubMed ID: 22064661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keeping promises: translating basic research into new spinal cord injury therapies.
    Kleitman N
    J Spinal Cord Med; 2004; 27(4):311-8. PubMed ID: 15484661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations and recommendations for selection and utilization of upper extremity clinical outcome assessments in human spinal cord injury trials.
    Jones LAT; Bryden A; Wheeler TL; Tansey KE; Anderson KD; Beattie MS; Blight A; Curt A; Field-Fote E; Guest JD; Hseih J; Jakeman LB; Kalsi-Ryan S; Krisa L; Lammertse DP; Leiby B; Marino R; Schwab JM; Scivoletto G; Tulsky DS; Wirth E; Zariffa J; Kleitman N; Mulcahey MJ; Steeves JD
    Spinal Cord; 2018 May; 56(5):414-425. PubMed ID: 29284795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication and reproducibility in spinal cord injury research.
    Steward O; Popovich PG; Dietrich WD; Kleitman N
    Exp Neurol; 2012 Feb; 233(2):597-605. PubMed ID: 22078756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenges of translating stem cells for spinal cord injury and related disorders: what are the barriers and opportunities?
    Hewson SM; Fehlings LN; Messih M; Fehlings MG
    Expert Rev Neurother; 2013 Feb; 13(2):143-50. PubMed ID: 23368801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.